Dicerna Pharma (DRNA) Files $130M Mixed Shelf

October 13, 2016 8:52 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Dicerna Pharma (NASDAQ: DRNA) filed a registration with the U.S. SEC to sell up to $130 million of mixed securities.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Related Entities


Add Your Comment